RMD vs UPXI · P/E 29, rev $5.65B vs P/E 1.8, rev $15.8M
ResMed Inc (RMD) versus Upexi Inc. (UPXI) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Upexi Inc. (UPXI) is a internet content & information company listed on NASDAQ.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported UPXI revenue for 2025-06-30 was $15.8M. Net income was -$13.7M. UPXI currently screens at market cap $65.3M and trailing P/E 1.8.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. UPXI currently screens at market cap $65.3M and trailing P/E 1.8.
Not investment advice. Open the RMD and UPXI stock pages for the full models.
Not investment advice.